Tag: latent TB screening

TNF Inhibitors and TB Reactivation: Screening and Monitoring Protocols

TNF Inhibitors and TB Reactivation: Screening and Monitoring Protocols

TNF inhibitors like adalimumab and infliximab effectively treat autoimmune diseases but carry a significant risk of reactivating latent tuberculosis. Proper screening, treatment of latent TB, and ongoing monitoring are essential to prevent life-threatening complications.